![The breaking news round-up: Decagear launches today, Pimax announces new headsets, and more! [APRIL FOOL’S]](https://i0.wp.com/skarredghost.com/wp-content/uploads/2025/03/lawk_glasses_handson.jpg?fit=1366%2C1025&ssl=1)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
One of Novartis’ most important clinical catalysts of the year came Thursday, wi...
Sarepta and Roche are hitting the brakes on three trials of their Duchenne gene ...
A few cell and gene therapy biotechs are doing alright this week. The latest...
A rapid cascade of seemingly conflicting details from President Donald Trump’s t...
President Donald Trump on Wednesday announced broad global tariffs, including a ...
This week’s sweeping layoffs at the FDA have caused some biopharma leaders to ch...
The FTC’s legal fight against three major pharmacy benefit managers is on hold a...
New FDA Commissioner Marty Makary took to the stage at the agency's Maryland hea...
Plus, news about Sumitomo Pharma, Gilead, Roche, Desentum, Inhibrx and Pila Phar...
Eli Lilly’s direct-to-consumer service has added another telehealth startup to i...
John Crowley is clear-eyed about the obstacles he faces. As CEO of the trade gro...
Tang Capital's shell company Concentra Biosciences secured its first major deal ...
Plus, news about Gilead, Roche, Desentum, Inhibrx and Pila Pharma: After 202...
Can AI make an avatar of Mikael Dolsten? The former chief scientific officer of ...
There's still money to be raised by gene therapy startups with good clinical dat...
Edgewise Therapeutics’ cardiac sarcomere modulator has passed a mid-stage test i...